Hepatocarcinomul celular: răspândire, factori de risc şi obţiuni de tratament
Close
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
738 6
Ultima descărcare din IBN:
2021-11-10 10:49
SM ISO690:2012
TARAN, Natalia, DUMBRAVA, Vlada-Tatiana, TOFAN-SCUTARU, Liudmila. Hepatocarcinomul celular: răspândire, factori de risc şi obţiuni de tratament. In: Sănătate Publică, Economie şi Management în Medicină , 2014, nr. 5(56), pp. 138-142. ISSN 1729-8687.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Sănătate Publică, Economie şi Management în Medicină
Numărul 5(56) / 2014 / ISSN 1729-8687 /ISSNe 2587-3873

Hepatocarcinomul celular: răspândire, factori de risc şi obţiuni de tratament

Hepatocellular carcinoma: spreading, risk factors and treatment options

Гепатоцелюлярная карцинома: распространенность, факторы риска и варианты лечения


Pag. 138-142

Taran Natalia, Dumbrava Vlada-Tatiana, Tofan-Scutaru Liudmila
 
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
 
Disponibil în IBN: 15 ianuarie 2018


Rezumat

Liver cancer ranks the 6th place in the structure of oncological morbidity (749000 new cases) and third in cancer mortality structure (692000), representing 7% of all cancer cases. HCC represents more than 90% of primary liver cancer, being the primordial public health problem worldwide. Globally, approximately 54% of HCC cases causally relate to viral hepatitis B (400 million people), 31% of cases are caused by viral hepatitis C (170 million people infected) and the rest – 15% have other causes. The basic treatment of HCC is surgical. When properly selected, candidates resection and liver transplantation offers the best option for development (5-year survival rate is achieved in 60-80% of cases) and there are methods of choice in patients with early-stage tumors.

Рак печени занимает 6-е место в структуре онкологической заболеваемости (749000 новых случаев) и 3-е место в структуре онкологической смертности (692000 случаев) и составляет 7% всех случаев рака. На ГЦК приходится более 90% первичных раковых опухолей печени, что представляет большую проблему здравоохранения во всем мире. В мире около 54% случаев ГЦК связаны с гепатитом В (им страдает 400 млн. человек), 31% случаев обусловлены гепатитом С (им заражено 170 млн. человек), а остальные 15% приходятся на другие причины. Основное лечение ГЦК — хирургическое. У хорошо подобранных кандидатов резекция и трансплантация печени обеспечивают наилучшие исходы (5-летняя выживаемость достигает 60–80%) и служат методом выбора у пациентов с ранней стадией опухоли.

Cuvinte-cheie
viral chronic hepatitis, liver cirrhosis, hepatocellular carcinoma, risk factors, treatment methods,

liver transplantation

Crossref XML Export

<?xml version='1.0' encoding='utf-8'?>
<doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'>
<head>
<doi_batch_id>ibn-58225</doi_batch_id>
<timestamp>1714546426</timestamp>
<depositor>
<depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name>
<email_address>idsi@asm.md</email_address>
</depositor>
<registrant>Asociaţia Economie, Management şi Psihologie în Medicină</registrant>
</head>
<body>
<journal>
<journal_metadata>
<full_title>Sănătate Publică, Economie şi Management în Medicină </full_title>
<issn media_type='print'>17298687</issn>
</journal_metadata>
<journal_issue>
<publication_date media_type='print'>
<year>2014</year>
</publication_date>
<issue>5(56)</issue>
</journal_issue>
<journal_article publication_type='full_text'><titles>
<title>Hepatocarcinomul celular: răsp&acirc;ndire, factori de risc şi obţiuni de tratament</title>
</titles>
<contributors>
<person_name sequence='first' contributor_role='author'>
<given_name>Natalia</given_name>
<surname>Taran</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Vlada-Tatiana</given_name>
<surname>Dumbrava</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Liudmila</given_name>
<surname>Tofan-Scutaru</surname>
</person_name>
</contributors>
<publication_date media_type='print'>
<year>2014</year>
</publication_date>
<pages>
<first_page>138</first_page>
<last_page>142</last_page>
</pages>
</journal_article>
</journal>
</body>
</doi_batch>